Keywords: update, alkermes, acquire, reliant, 934m, deal, signed

Update: Alkermes to acquire Reliant in $934M deal

Article | 01 April 2002

Print This

Alkermes has signed a definitive agreement to acquire fellow US firmReliant Pharmaceuticals in a stock deal valued at $934 million, based ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in